药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Potassium cation
Difemerine
The risk or severity of Tachycardia and drowsiness can be increased when Difemerine is combined with Cannabidiol.
Potassium cation
Benzilone
The risk or severity of Tachycardia and drowsiness can be increased when Benzilone is combined with Cannabidiol.
Potassium cation
Piperidolate
The risk or severity of Tachycardia and drowsiness can be increased when Piperidolate is combined with Cannabidiol.
Potassium cation
Prifinium
The risk or severity of Tachycardia and drowsiness can be increased when Prifinium is combined with Cannabidiol.
Potassium cation
Tropatepine
The risk or severity of Tachycardia and drowsiness can be increased when Tropatepine is combined with Cannabidiol.
Potassium cation
Mebeverine
The risk or severity of Tachycardia and drowsiness can be increased when Mebeverine is combined with Cannabidiol.
Potassium cation
Batefenterol
The risk or severity of Tachycardia and drowsiness can be increased when Batefenterol is combined with Cannabidiol.
Potassium cation
Propiverine
The risk or severity of Tachycardia and drowsiness can be increased when Propiverine is combined with Cannabidiol.
Potassium cation
Oxitropium
The risk or severity of Tachycardia and drowsiness can be increased when Oxitropium is combined with Cannabidiol.
Potassium cation
Methscopolamine
The risk or severity of Tachycardia and drowsiness can be increased when Methscopolamine is combined with Cannabidiol.
Potassium cation
Thonzylamine
The risk or severity of Tachycardia and drowsiness can be increased when Thonzylamine is combined with Cannabidiol.
Potassium cation
Butylscopolamine
The risk or severity of Tachycardia and drowsiness can be increased when Butylscopolamine is combined with Cannabidiol.
Potassium cation
Imidafenacin
The risk or severity of Tachycardia and drowsiness can be increased when Imidafenacin is combined with Cannabidiol.
Potassium cation
Trimebutine
The risk or severity of Tachycardia and drowsiness can be increased when Trimebutine is combined with Cannabidiol.
Potassium cation
Umeclidinium
The risk or severity of Tachycardia and drowsiness can be increased when Umeclidinium is combined with Cannabidiol.
Potassium cation
Dexetimide
The risk or severity of Tachycardia and drowsiness can be increased when Dexetimide is combined with Cannabidiol.
Potassium cation
Aclidinium
The risk or severity of Tachycardia and drowsiness can be increased when Aclidinium is combined with Cannabidiol.
Potassium cation
Dimetindene
The risk or severity of Tachycardia and drowsiness can be increased when Dimetindene is combined with Cannabidiol.
Potassium cation
Hexocyclium
The risk or severity of Tachycardia and drowsiness can be increased when Hexocyclium is combined with Cannabidiol.
Potassium cation
Mepenzolate
The risk or severity of Tachycardia and drowsiness can be increased when Mepenzolate is combined with Cannabidiol.